| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
6e-05 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
7e-05 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-05 |
| mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.17 |
0.0004 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
| mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |